Eastman Chemical backs FY24 EPS view of $7.25-$8.00, consensus $7.66

Commenting on the outlook for full-year 2024, CEO Mark Costa said: “We delivered strong first-quarter results that were above our expectations, reflecting both better than expected sales volume/mix and continued pricing discipline. We are encouraged to see continued evidence that customer inventory destocking is behind us across most of our key end markets. Looking forward to the remainder of the year, primary demand in key markets and geographies remains uncertain. However, we continue to benefit from our innovation-driven growth model that enables growth above our end markets. We also expect to benefit from revenue and earnings generated by our Kingsport methanolysis facility, mostly in the second half of the year. We expect continued pricing discipline and improving asset utilization throughout the year. Taking these drivers together, we continue to expect 2024 EPS to be between $7.25 and $8.00 and for 2024 cash from operations to be approximately $1.4 billion.”